We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Gazyva
Australian Public Assessment Report
Device/Product Name
Gazyva
Active ingredients
Obinutuzumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2022-03031-1-6
Submission Type
Extension of indication
Decision
Approved